My research is focused on determining how alterations in activity of a transcription factor can have wide-ranging downstream effects on multiple cellular pathways and other regulatory mechanisms (miRNAs) in healthy and disease states. I integrate Next-Gen sequencing, neuroscience, biochemistry, primary neurons, and preclinical trials with mouse models to generate and test novel therapeutic interventions in Huntington’s disease and Parkinson’s disease. I am also fascinated by how mitochondria can affect the development of neurons, and their response to ‘insult’ whether stroke or disease. I enjoy training and mentoring other scientists to undertake meaningful large-scale research projects and achieve high-quality results in a timely fashion.